中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Journal of Allergy and Clinical Immunology: In Practice 2020-Feb

Burden of Specialist-Diagnosed Chronic Cough in Adults.

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
Robert Zeiger
Michael Schatz
Rebecca Butler
Jessica Weaver
Vishal Bali
Wansu Chen

关键词

抽象

The burden of chronic cough (CC) in patients seeking specialist care is infrequently researched.To describe patient characteristics and disease burden associated with specialist-diagnosed CC.Using administrative pharmacy and medical data, we identified patients ages 18-85 years with CC diagnosed by pulmonologists, allergists, otolaryngologists, or gastroenterologists. Patients were stratified into 4 subgroups based on presence or absence of common respiratory diseases or gastroesophageal reflux disease (GERD). Clinical features and healthcare resource utilization (HCRU) in the baseline and outcome years were compared between the CC subgroups. Also determined were the baseline factors associated with persistence of CC and a comparison of the CC cohort to a matched non-cough cohort.The 11,290 patients with specialist-diagnosed CC were about 61 years of age and 66.7% female. The CC cohort experienced frequent GERD (44.1%), asthma (31.2%), obesity (24.3%), upper airway cough syndrome (20.4%), common cough complications (19.4%), and hospitalizations (9.8%). The CC patients with both respiratory disease and GERD exhibited at baseline and follow-up: the most common cough comorbidities, higher HCRU, specialist care, dispensed respiratory and non-respiratory medications including proton pump inhibitors, antitussives, psychotherapeutics, oral corticosteroids and antibiotics than the other subgroups. A 40.6% persistence of CC occurred similarly between CC subgroups. Additionally, CC patients in the matched analysis also experienced significantly more comorbidities, laboratory evaluations, HRCU, and antitussives than non-cough patients.Specialist-diagnosed CC was associated with considerable disease burden, particularly among those with both respiratory disease and GERD. Additionally, CC burden was more pronounced than in matched non-cough patients.

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge